Artificial intelligence for dementia-Applied models and digital health
- PMID: 37496259
- PMCID: PMC10955778
- DOI: 10.1002/alz.13391
Artificial intelligence for dementia-Applied models and digital health
Abstract
Introduction: The use of applied modeling in dementia risk prediction, diagnosis, and prognostics will have substantial public health benefits, particularly as "deep phenotyping" cohorts with multi-omics health data become available.
Methods: This narrative review synthesizes understanding of applied models and digital health technologies, in terms of dementia risk prediction, diagnostic discrimination, prognosis, and progression. Machine learning approaches show evidence of improved predictive power compared to standard clinical risk scores in predicting dementia, and the potential to decompose large numbers of variables into relatively few critical predictors.
Results: This review focuses on key areas of emerging promise including: emphasis on easier, more transparent data sharing and cohort access; integration of high-throughput biomarker and electronic health record data into modeling; and progressing beyond the primary prediction of dementia to secondary outcomes, for example, treatment response and physical health.
Discussion: Such approaches will benefit also from improvements in remote data measurement, whether cognitive (e.g., online), or naturalistic (e.g., watch-based accelerometry).
Keywords: AI; ML; applied models; artificial intelligence; dementia; digital health; machine learning.
© 2023 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
Conflict of interest statement
Dr Kormilitzin declares research grant funding from GlaxoSmithKline. The views expressed are those of the authors and not necessarily those of the UK National Health Service, the NIHR or the UK Department of Health. All other co‐authors have no conflicts of interest to disclose.disclosures are available in the supporting information.
